Clinical Trial Update: Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the safety and efficacy of the fluocinolone acetonide intravitreal implant for non-infectious uveitis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Uveitis

Drugs mentioned

• Retisert (fluocinolone acetonide)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Non-infectious Uveitis | Phase 2, Phase 3 | Status: TERMINATED